BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse upgrades GSK Consumer to outperform
GSK now trades at 15 per cent price earnings discount to its MNC peers. GSK has high earnings growth of around 18 per cent. GSK's ebitda margins are at a 20-year low. Rural distribution should double in 2-3 years.